Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2025-12-28 @ 12:38 PM
Study NCT ID:
NCT05236257
Status:
COMPLETED
Last Update Posted:
2024-12-10
First Post:
2022-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-13
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-02
First Submit QC Date:
None
Study First Post Date:
2022-02-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-11
Results First Submit QC Date:
None
Results First Post Date:
2024-12-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-08
Last Update Post Date:
2024-12-10
Last Update Post Date Type:
ACTUAL